Record Number of Pipeline Advancements Underscore R&D Leadership; Strong U.S. Seed Order Book Reinforces Positive MomentumMonsanto Company (NYSE: MON) delivered above-estimate results for the first quarter of its fiscal year 2012 and pointed to the high end of its previously reported earnings per share guidance for the year on the strength of its seed business. The company also previewed a strong U.S. order book and announced 14 phase advancements across its breeding, biotechnology, and chemistry and agronomic research and development platforms, representing a record number of advancements for its annual pipeline update.
For more information, please click here.
Copyright 2012 Monsanto All Rights Reserved